Molecular CellBioinformaticsPeer-reviewed journal article
DeorphaNN: Virtual screening of GPCR peptide agonists using AlphaFold-predicted active-state complexes and deep learning embeddings
Larissa FergusoniD, Sébastien OuelletiD, Elke VandewyeriD, Christopher Wang, Zaw Wunna, Tony K.Y. LimiD, William R SchaferiD, Isabel BeetsiD
Abstract
Peptide-activated G protein-coupled receptors (GPCRs) regulate critical physiological processes such as metabolism, neural signalling, and endocrine function through their interaction with neuropeptides and peptide hormones. Despite their importance, identifying endogenous peptide agonists for GPCRs remains challenging, particularly for orphan receptors without known ligands. Recent advances in deep learning-based protein structure prediction, exemplified by AlphaFold (AF), have shown application beyond structural modelling, including protein-protein interaction prediction. Given that GPCR-peptide agonist interactions represent a specialized form of protein-protein interaction, we leveraged a dataset of experimentally validated agonist and non-agonist GPCR-peptide interactions from Caenorhabditis elegans to evaluate AF-Multimers ability to distinguish agonist-bound complexes. When modelling GPCR-peptide complexes, AF-Multimer confidence metrics partially discriminate agonist from non-agonist interactions, with improved discrimination achieved by utilizing AF-Multistate-derived active-state templates. We further investigated whether embeddings from the hidden layer of AF-Multimers neural network could distinguish agonist from non-agonist complexes. Feature performance analysis reveals that AF- Multimers pair representations outperform single representations, with distinct subregions of the pair representation providing complementary predictive signals. Building on these insights, we developed DeorphaNN, a graph neural network integrating active-state GPCR-peptide structural predictions, interatomic interactions, and deep learning embeddings to prioritize GPCR-peptide agonist interactions. DeorphaNN generalizes across datasets derived from different species, including annelids and humans, and successfully uncovered peptide agonists for two orphan GPCRs. DeorphaNN offers a novel computational resource to accelerate deorphanization by prioritizing GPCR-peptide agonist candidates for AI-guided experimental validation.
- organism: C. elegans
- organism: human
- organism: multiple species
- assay: protein structure
- research focus: drug response / drug discovery
- research focus: benchmarking
- research focus: database / resource
- research focus: software / tool
- approach: deep learning
- approach: graph neural network
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 45th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Geometric-Evolutionary Deep Learning Decodes the Human GPCR-Metabolome Interactome and Enables Systematic De-Orphanization
Tomoya Sakuma, Yuki Otani, Hideyuki Shimizu·bioRxiv·Feb 23, 2026
- Revolutionizing GPCR-Ligand Predictions: DeepGPCR with experimental Validation for High-Precision Drug Discovery
Haiping Zhang, Hongjie Fan, … Yang Chen·Briefings in BioinformaticsPeer-reviewed·May 23, 2024
- AlphaFold prediction and analysis of Adhesion-family G protein coupled receptor (aGPCR) structures.
Xiao Wen (Kelly) Zhou, Eddie Chen, Rithwik Ramachandran·bioRxiv·Dec 17, 2024
- Identifying endogenous peptide receptors bycombining structure and transmembrane topologyprediction
Felix Teufel, Jan C. Refsgaard, … Dennis Madsen·bioRxiv·Oct 28, 2022
- RareFoldGPCR: Agonist Design Beyond Natural Amino Acids
Qiuzhen Li, Thomas Helleday, Patrick Bryant·bioRxiv·Oct 1, 2025
- Assessment of Generative De Novo Peptide Design Methods for G Protein-Coupled Receptors
Hannes Junker, Clara T. Schoeder·bioRxiv·Mar 2, 2026